FDA Advisory Committee Votes Unanimously to Confirm the Clinical Benefit of LEQEMBI®…
Peripheral and Central Nervous System Drugs Advisory Committee voted based on data from large global confirmatory Phase 3 Clarity AD clinical trial in patients living with early Alzheimer’s…